Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.59
+7.67 (2.59%)
At close: Jun 26, 2026, 4:00 PM EDT
303.00
-0.59 (-0.19%)
After-hours: Jun 26, 2026, 5:54 PM EDT
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Ligand Pharmaceuticals stock have an average target of 280.14, with a low estimate of 255 and a high estimate of 330. The average target predicts a decrease of -7.72% from the current stock price of 303.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ligand Pharmaceuticals stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $330 | Buy | Reiterates | $330 | +8.70% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $266 | Buy | Maintains | $266 | -12.38% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $262 | Buy | Reiterates | $262 | -13.70% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $289 | Buy | Reiterates | $289 | -4.81% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $230 → $255 | Buy | Reiterates | $230 → $255 | -16.01% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
287.66M
from 268.09M
Increased by 7.30%
Revenue Next Year
370.56M
from 287.66M
Increased by 28.82%
EPS This Year
9.10
from 8.13
Increased by 11.95%
EPS Next Year
11.32
from 9.10
Increased by 24.34%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 309.7M | 398.2M | |
| Avg | 287.7M | 370.6M | |
| Low | 278.9M | 346.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.5% | 38.4% | |
| Avg | 7.3% | 28.8% | |
| Low | 4.0% | 20.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.67 | 12.58 | |
| Avg | 9.10 | 11.32 | |
| Low | 8.79 | 10.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.9% | 38.2% | |
| Avg | 11.9% | 24.3% | |
| Low | 8.1% | 14.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.